Wolters Kluwer Health – Lippincott Williams & Wilkins (LWW) offers peer-reviewed open access options to meet the needs of authors and maximize article visibility. Options include hybrid open access models across a number of journal publications, as well as fully open access specialty titles.
Wolters Kluwer Health – LWW Open Access publishing offers authors, institutions, research funding agencies, and others high-quality publishing services including:
- Innovative publishing platform from Lippincott Williams & Wilkins
- Globally distribution of freely available, quality open access research on our journals platform
- Article deposit in PubMed Central
- Rapid publication
- Posts on Websites and Intranets
- Rigorous peer review
- High-quality editorial services and support
- Library reserves and E-reserves
- Compliance with federal funding mandates such as NIH, RCUK, and Wellcome Trusts
LWW titles offering open access options
View the complete list of titles offering open access options and related publication charges.
Hybrid open access
LWW’s hybrid open access option is offered to authors whose articles have been accepted for publication. With this choice, articles are made freely available online immediately upon publication. Authors may take advantage of the open access option at the point of revision. These articles are subject to the journal’s standard peer-review process and will be accepted or rejected based on their own merit.
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. The publication fee is charged on acceptance of the article and should be paid within 30 days by credit card by the author, funding agency or institution. Payment must be received in full for the article to be published open access.
Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access. Authors grant LWW a license to publish the article and identify itself as the original publisher.
Creative Commons license
Articles opting for open access will be freely available to read, download and share from the time of publication. All open access articles (with the exception of the Research Councils UK funded papers) are published under the terms of the Creative Commons License Attribution-Noncommercial No Derivative 3.0 (CCBY NCND) which allows readers to disseminate and reuse the article, as well as share and reuse of the scientific material. It does not permit commercial exploitation or the creation of derivative works without specific permission. To view a copy of this license visit: http://creativecommons.org/licenses/by-nc-nd/3.0. Authors who are funded by the Research Councils UK and wish to publish their article as open access will be able to publish under the terms of the Attribution 3.0 (CCBY) License. To view of a copy of this license visit: http://creativecommons.org/licenses/by/2.0/.
Reuse of all Wolters Kluwer Health- LWW Open Access articles is governed by the terms of a Creative Commons user license.
With each Creative Commons license, the reuse of an article requires proper attribution of the original work. Whether you reuse, display, or repost an article, the user must attribute the article to the original author.
Below are guidelines on what type of reuse is permitted under different Creative Commons licenses.
||Who has reuse rights
||Redistribute article: print, hand out, display
||Reuse or modify figures, tables, images, or extracts from article
||Reuse for commercial purposes
||Text & data mine
|CCBY NC ND
||Anyone – except for commercial purposes
||Anyone – except for commercial purposes
*To reuse a figure, table, or image from an article with CCBY-NC-ND licensing, Wolters Kluwer Health has partnered with Copyright Clearance Center's Rightslink service. Article-specific Rightslink information can be accessed directly from articles on the journal website.
For additional information on Creative Commons licenses visit their website: http://creativecommons.org/licenses/.
Compliance with NIH, RCUK and other research funding agency accessibility requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW identifies to the National Library of Medicine (NLM) articles that require deposit and transmits the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism. LWW ensures that authors can fully comply with the public access requirements of major funding bodies worldwide. Additionally, all authors who choose the open access option will have their final published article deposited into PubMed Central.
RCUK funded authors can choose to publish their paper as open access with the payment of an article process charge, or opt for their accepted manuscript to be deposited (green route) into PMC with an embargo.
With both the gold and green open access options, the author will continue to sign the Copyright Transfer Agreement (CTA) as it provides the mechanism for LWW to ensure that the author is fully compliant with the requirements. After signature of the CTA, the author will then sign a License to Publish where they will then own the copyright.
It is the responsibility of the author to inform the Editorial Office and/or LWW that they have RCUK funding. LWW will not be held responsible for retroactive deposits to PMC if the author has not completed the proper forms.
View Frequently Asked Questions for more information on the program.